Member Info for AATHOMOZ

OGM. That’s a very interesting read - thank you for posting.

I am also following Solvonis closely and the CEO there often refers to the ‘patent cliff’ that big pharma are facing over the next 2 years.

It’s real.

When has it ever been readable?

Hard to buy or sell though

Top of the risers!

I just took a punt for £2.5k across 2 tranches

Issued new shares at £1.60 - is that not a huge premium??

Ridiculous drop!

It is. Just look at what’s in front of you, what you’ve been told by the company and ignore the clowns on here.

Tim (the CEO of a plc in one of the most heavily regulated markets in the world) compared this to Humira and said the SP improvement experienced in recent weeks was “just the start”.

It’s actually pretty easy.

Diary entry, 17th September 2025:

Today, I unfortunately shat my pants and sold up on a stock that could have changed my life.

It turns out I don’t have the testes required for AIM stock.

Lesson learnt.

ChatGPT literally quotes this board as source data - how can that be fun?

Highland. ChatGPT answers are never ‘fun’.

Also, you need to factor in warrant holders so you should use more like 650m shares for full dilution.

Tbf - you can’t blame PIs for getting out when so many of them will have made 1.5-5x their investment.

However you have to think all those that were going to get out, are now out.

So this has a clear runway once more, carrying proper II money who aren’t checking their phones every 5 mins and getting rattled by intraday movements.

If I open my window, I can actually hear a collective cry of “oops”

Silly sellers.

Silentmystic. I have seen some posts in my time (mainly from Tiger16), however you’ve just won the ‘new low’ award.

Stick to claiming your dole money.

“Just the start”

“A damage assessment”

This board is fcking hilarious.

People forgot this was 1.5p two weeks ago? Stop losing your minds.

MMs win again - going to be some very sick people in a few weeks after all those silly sells this morning.

People need more resilience for AIM stock.

But this is such a hard one to value as a PI. They’ll have consultants all over this to provide valuation estimates.

If I’m honest - I’d sooner a buyout so I don’t have to decide at what price to sell!!

I would not rule out a buyout. Everyone has a number.

Just a public announcement.

Everyone should completely ignore the Immupharma scientists who have had their tireless work of 3 years validated by the highly revered Jackson Labs in the USA, and just take all their scientific insights from TimSmith from LSE.